cyproterone acetate
Sponsors
NCIC Clinical Trials Group, Barr Laboratories, St. Bartholomew's Hospital, Institut National de la Santé Et de la Recherche Médicale, France, European Organisation for Research and Treatment of Cancer - EORTC
Conditions
Adenocarcinoma, ProstateGender DysphoriaHot FlashesHyperandrogenismMetabolic Cardiovascular SyndromePedophiliaProstate CancerProstate Hyperplasia
Early Phase 1
Phase 3
Cyproterone Acetate in Treating Hot Flashes Following Surgical or Chemical Castration for Prostate Cancer
CompletedNCT00005623
Start: 1999-12-31End: 2004-01-31Updated: 2013-03-26
Hormone Therapy in Treating Patients With Rising PSA Levels Following Radiation Therapy for Prostate Cancer
CompletedNCT00003653
Start: 1999-01-05End: 2013-01-10Updated: 2021-06-23
Cyproterone Acetate in Treating Patients With Newly Diagnosed Stage III or Stage IV Prostate Cancer
NCT00363285
Start: 2003-01-31Target: 900Updated: 2013-08-26
Comparison of Two Pharmacological Treatments of Pedophilia
TerminatedNCT00601276
Start: 2007-12-31End: 2009-06-30Target: 48Updated: 2009-07-13
Radiation Therapy With or Without Goserelin and Cyproterone in Treating Patients With Prostate Cancer
CompletedNCT00849082
Start: 1987-05-31Updated: 2012-07-11
Treatment of Hot Flushes Caused by Leuprorelin 11.25 mg in Prostate Adenocarcinoma
CompletedNCT01011751
Start: 2004-04-30End: 2007-12-31Updated: 2015-07-30